Literature DB >> 29556316

Tumor suppressor microRNA-136-5p regulates the cellular function of renal cell carcinoma.

Peijie Chen1,2,3, Liwen Zhao1,3, Xiang Pan1, Lu Jin1,3, Canbin Lin1,2,3, Weijie Xu1, Jinling Xu1, Xin Guan1, Xueling Wu4, Yong Wang5, Shangqi Yang1, Tao Wang6, Yongqing Lai1,3.   

Abstract

MicroRNAs (miRs) are involved in diverse physiological and developmental processes at the post-transcriptional level in cells. Previous studies have demonstrated that miR-136-5p is involved in certain types of cancer. However, the function of miR-136-5p in renal cell carcinoma (RCC) remains to be fully elucidated. In present study, miR-136-5p expression levels were determined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and MTT assays, CCK-8 assays, Transwell assays, wound healing assays and flow cytometry were performed to investigate the function of miR-136-5p in RCC. RT-qPCR revealed that the expression of miR-136 was significantly lower in RCC tissues and cells compared with adjacent non-tumor tissues and cells in vitro. miR-136-5pwas also demonstrated to be associated with RCC cell proliferation, viability, migration, invasion and apoptosis. miR-136-5p may therefore function as a tumor suppressor in RCC. Further studies are required to elucidate the molecular mechanisms and signaling pathways underlying these functions of miR-136-5p, to investigate the potential function of miR-136-5p as a biomarker for the early detection and prognosis of RCC, and its potential as a therapeutic target for the treatment of RCC.

Entities:  

Keywords:  microRNA-136-5p; renal cell carcinoma; suppressor

Year:  2018        PMID: 29556316      PMCID: PMC5844007          DOI: 10.3892/ol.2018.8081

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  Placental-specific microRNA in maternal circulation--identification of appropriate pregnancy-associated microRNAs with diagnostic potential.

Authors:  Katerina Kotlabova; Jindrich Doucha; Ilona Hromadnikova
Journal:  J Reprod Immunol       Date:  2011-04-21       Impact factor: 4.054

4.  Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A.

Authors:  Sining Shen; Han Yue; Yin Li; Jianjun Qin; Ke Li; Ying Liu; Jiaxiang Wang
Journal:  Tumour Biol       Date:  2014-01

5.  Identification of potential biomarkers for clear cell renal cell carcinoma based on microRNA-mRNA pathway relationships.

Authors:  Jun-Feng Hao; Kai-Ming Ren; Jiu-Xu Bai; Shou-Nan Wang; Bing Shao; Ning Cao; Xu Li
Journal:  J Cancer Res Ther       Date:  2014-11       Impact factor: 1.805

Review 6.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

7.  HBx elevates oncoprotein AEG-1 expression to promote cell migration by downregulating miR-375 and miR-136 in malignant hepatocytes.

Authors:  Jing Zhao; Wenjie Wang; Yuxian Huang; Jing Wu; Mingquan Chen; Peng Cui; Wenhong Zhang; Ying Zhang
Journal:  DNA Cell Biol       Date:  2014-07-22       Impact factor: 3.311

8.  Targeting Smad2 and Smad3 by miR-136 suppresses metastasis-associated traits of lung adenocarcinoma cells.

Authors:  Yi Yang; Lei Liu; Junchao Cai; Jueheng Wu; Hongyu Guan; Xun Zhu; Jie Yuan; Shengping Chen; Mengfeng Li
Journal:  Oncol Res       Date:  2013       Impact factor: 5.574

9.  Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer.

Authors:  Hongyan Gao; Xiaodi Song; Ting Kang; Baohong Yan; Li Feng; Li Gao; Liang Ai; Xiaoni Liu; Jie Yu; Huiqi Li
Journal:  Onco Targets Ther       Date:  2017-01-05       Impact factor: 4.147

10.  Management of metastatic renal cell carcinoma - mini review.

Authors:  Anubha Bharthuar; Himanshu Pandey; Swapan Sood
Journal:  J Kidney Cancer VHL       Date:  2015-05-05
View more
  14 in total

1.  Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.

Authors:  Yanchen Chu; Xiaoli Hu; Guangfeng Wang; Zhijie Wang; Yanjin Wang
Journal:  Oncol Lett       Date:  2019-04-01       Impact factor: 2.967

2.  The tumor suppressor function of hsa_circ_0006282 in gastric cancer through PTEN/AKT pathway.

Authors:  Zhe Li; Yi Xie; Bingxiu Xiao; Junming Guo
Journal:  Int J Clin Oncol       Date:  2022-07-07       Impact factor: 3.850

3.  Circular RNA profile identifies circOSBPL10 as an oncogenic factor and prognostic marker in gastric cancer.

Authors:  Sen Wang; Xing Zhang; Zheng Li; Weizhi Wang; Bowen Li; Xiaoxu Huang; Guangli Sun; Jianghao Xu; Qing Li; Zhipeng Xu; Yiwen Xia; Lu Wang; Qiang Zhang; Qiang Li; Lu Zhang; Jie Chen; Yangjun Wu; Jiacheng Cao; Penghui Xu; Diancai Zhang; Hao Xu; Zekuan Xu
Journal:  Oncogene       Date:  2019-08-13       Impact factor: 9.867

4.  Long non-coding RNA NORAD induces phenotypic regulation of vascular smooth muscle cells through regulating microRNA-136-5p-targeted KDM1A.

Authors:  Chao Lv; Jun Wang; Shuhui Dai; Yanwei Chen; Xiaofan Jiang; Xia Li
Journal:  Cell Cycle       Date:  2021-09-29       Impact factor: 5.173

5.  CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p.

Authors:  Jianfa Li; Chenchen Huang; Yifan Zou; Jing Ye; Jing Yu; Yaoting Gui
Journal:  Mol Cancer       Date:  2020-06-05       Impact factor: 27.401

Review 6.  The Role of ERα36 in Development and Tumor Malignancy.

Authors:  Charlène Thiebaut; Henri-Philippe Konan; Marie-Justine Guerquin; Amand Chesnel; Gabriel Livera; Muriel Le Romancer; Hélène Dumond
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

Review 7.  Dysregulation of ncRNAs located at the DLK1‑DIO3 imprinted domain: involvement in urological cancers.

Authors:  Jiangfeng Li; Haixiang Shen; Haiyun Xie; Yufan Ying; Ke Jin; Huaqing Yan; Song Wang; Mingjie Xu; Xiao Wang; Xin Xu; Liping Xie
Journal:  Cancer Manag Res       Date:  2019-01-15       Impact factor: 3.989

8.  Expression of CREPT is associated with poor prognosis of patients with renal cell carcinoma.

Authors:  Huaqi Yin; Qingfei Cao; Haiyue Zhao; Shenheng Wang; Weinan Chen; Xiaowei Zhang; Zhijie Chang; Tao Xu; Xiongjun Ye
Journal:  Oncol Lett       Date:  2019-09-09       Impact factor: 2.967

9.  Integrated analysis of a competing endogenous RNA network in renal cell carcinoma using bioinformatics tools.

Authors:  Wei-Dong Jiang; Zhi-Hua Ye
Journal:  Biosci Rep       Date:  2019-07-05       Impact factor: 3.840

10.  LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.

Authors:  Chunyong Han; Yiwei Fu; Ni Zeng; Jian Yin; Qian Li
Journal:  Aging (Albany NY)       Date:  2020-02-17       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.